Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Induction FLOT With CROSS CRT for Esophageal Cancer

This study evaluates a novel regimen of induction chemotherapy using a combination of docetaxel, oxaliplatin, and leucovorin, with short term infusional 5-FU (FLOT), given prior to chemoradiotherapy with concurrent carboplatin and paclitaxel, as neoadjuvant therapy prior to definitive surgical resection for patients with adenocarcinoma of the esophagus or gastroesophageal junction

chemoradiotherapy
tubal ligation
leucovorin
progestogen
carboplatin
  • 0 views
  • 28 Feb, 2021
  • 3 locations
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

This phase II trial studies how well pegylated liposomal doxorubicin hydrochloride and carboplatin followed by surgery and paclitaxel work in treating patients with stage II-III breast cancer that does not have estrogen receptors, progesterone receptors, or large amounts of human epidermal growth factor receptor 2 (HER2)/neu protein (triple negative). Drugs …

human chorionic gonadotropin
mammogram
epidermal growth factor receptor
beta human chorionic gonadotropin
beta-human chorionic gonadotropin
  • 1 views
  • 25 Jan, 2021
  • 1 location
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

RATIONALE: Giving chemotherapy before a peripheral blood stem cell transplant stops the growth of cancer cells by stopping them from dividing or by killing them. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy is given to prepare the bone marrow for the stem cell …

cytarabine
t-cell lymphoma
cancer
carmustine
high dose chemotherapy
  • 36 views
  • 07 Nov, 2020
  • 1 location
Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma

The best treatment for resectable esophageal or gastroesophageal adenocarcinoma is unknown. Although an operation to remove the esophagus is the most common treatment, previous studies have shown that patients live longer when either perioperative (before and after surgery) chemotherapy or preoperative (before surgery) chemotherapy plus radiation is given, compared to …

chemoradiotherapy
epirubicin
capecitabine
leucovorin
esophagus cancer
  • 7 views
  • 25 Jan, 2021
  • 2 locations
PD-1 Monoclonal Antibody Lenvatinib and TACE in the Treatment of HCC

The vast majority of primary liver cancer (90%) is hepatocellular carcinoma (HCC), and the majority of HCC patients have been locally advanced or metastatic disease when they are diagnosed in clinics. Most of them are not suitable for radical treatment. In the case of supportive treatment, the median survival time …

TACE
monoclonal antibodies
local therapy
liver cancer
cancer
  • 0 views
  • 24 Jan, 2021
  • 1 location
Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer

Although the intergroup 0116 trial was the first to demonstrate that adjuvant chemoradiotherapy offers a significant survival benefit in completely resected gastric cancer,it is more toxic and less effective. It is reasonable to optimize this regimen.

immunostimulants
fluorouracil
adenocarcinoma
docetaxel
leucovorin
  • 3 views
  • 25 Jan, 2021
  • 1 location
Herzuma-capecitabine/Cisplatin for Gastric Cancer

Stomach cancer is the fifth largest cancer in the world. Despite many combinations of studies, metastatic stomach cancer shows a median survival period of 10 to 12 months. According to a report in Korea in 2010, 17 % of cancer patients had over-expression of human epidemiology growth factor receptor 2 …

cancer
capecitabine
growth factor
adenocarcinoma
trastuzumab
  • 14 views
  • 22 Jan, 2021
  • 1 location
TACE Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death that ranks sixth in terms of incident cases, with an overall 5 years survival of 18%. Despite a significant improvement in treatment strategy, the overall survival of HCC remains low due to high recurrence, progressive liver dysfunction and …

carcinoma
TACE
monoclonal antibodies
monoclonal antibody
local therapy
  • 0 views
  • 26 Jan, 2021
  • 1 location
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia

Prevention and early detection of chemotherapy-induced cardiotoxicity in children with bone tumors and Acute Myeloid Leukemia by giving capoten

ewing's sarcoma
early detection
bone tumors
sarcoma
capoten
  • 49 views
  • 03 Feb, 2021
  • 2 locations
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

The purpose of this study is to determine if the combination of paclitaxel protein bound, gemcitabine, cisplatin, paricalcitol are effective in individuals with resectable and unresectable pancreatic cancer.

pdac
paclitaxel
paclitaxel protein bound
gemcitabine
neutrophil count
  • 4 views
  • 25 Jan, 2021
  • 1 location